MoCA/BEARNIMoCA and BEARNI Tests for Cognitive Disorders in UAS Patients
This study aims to observe and compare the effectiveness of the MoCA and BEARNI tests in detecting cognitive disorders in individuals with upper airway stenosis.
Data Collection
Collected from past medical records and data - RetrospectiveAlcoholism+2
+ Mental Disorders
+ Substance-Related Disorders
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: November 2, 2017
Actual date on which the first participant was enrolled.The study is designed to evaluate two different tests for detecting cognitive disorders in patients with Alcohol Use Disorder (AUD). Cognitive disorders can affect memory, thinking, and behavior, and identifying them early can help in managing these conditions better. The study compares a new test called BEARNI, which is specifically tailored for patients with alcohol-related issues, with an existing test known as MoCA. Both tests aim to identify cognitive impairments that could be linked to alcohol use, which is important for providing appropriate care and interventions for those affected. Participants in the study, who are hospitalized patients, take both the MoCA and BEARNI tests upon admission. If either test shows signs of cognitive problems, the patients undergo further detailed testing to confirm the results. The study looks at how sensitive each test is, meaning how well they identify those with cognitive disorders, and how specific they are, meaning how well they avoid false positives. This comparison helps determine which test is more reliable and effective for screening cognitive disorders in patients with AUD.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.90 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Conditions
Pathology
Criteria
Inclusion Criteria: * patients with alcoo use desorder * Patient cared for in the addictology department of the University Hospital of Nîmes Exclusion Criteria: * refusal to use the data
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location